EXELIXIS, INC.·4

Feb 23, 9:08 PM ET

Garber Alan M 4

4 · EXELIXIS, INC. · Filed Feb 23, 2023

Insider Transaction Report

Form 4
Period: 2023-02-21
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-21$6.30/sh+40,000$252,00071,417 total
  • Exercise/Conversion

    Option (right to buy)

    2023-02-2140,0000 total
    Exercise: $6.30From: 2016-05-26Exp: 2023-05-25Common Stock (40,000 underlying)
  • Sale

    Common Stock

    2023-02-21$17.49/sh40,000$699,60031,417 total
Footnotes (3)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 2, 2022.
  • [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.39 to $17.55. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  • [F3]The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016.

Documents

1 file
  • 4
    wf-form4_167720447178170.xmlPrimary

    FORM 4